Chronic Disease
-
Chronic Disease
Abbott Fined $160M to Resolve Medicare Diabetes Lawsuit
Resolves allegations Abbott companies Arriva and Alere made, or caused, claims to Medicare that were false.U.S. Department of Justice 08.02.21
-
Chronic Disease | Patient Monitoring | Software & IT
FDA OKs Abbott's FreeStyle Libre 2 iOS App
Users can check glucose with a compatible iPhone every minute with optional real-time glucose alarms.Abbott Laboratories 08.02.21
-
Chronic Disease
Rice Team Building Insulin-Producing Implant for Type 1 Diabetes
JDRF funds creation of implant to automatically regulate blood glucose levels.Jade Boyd, Rice University 07.27.21
-
Chronic Disease
Integra Highlights Data from Diabetic Foot Ulcer Study
Positive clinical outcomes for PriMatrix dermal repair scaffold for management of hard to heal diabetic foot ulcers.GlobeNewswire 07.20.21
-
Chronic Disease | Software & IT
Dexcom's Real-Time APIs for Third-Party Apps, Devices Earn FDA Nod
Gives Dexcom users more choice in where and how they interact with their glucose data.Business Wire 07.16.21
-
Chronic Disease
Bioventus Makes Minority Investment in Vaporox
Vaporox has developed an ultrasonic technology to heal diabetic foot ulcers.Bioventus 06.25.21
-
Chronic Disease
Philips, Elekta Expand Precision Oncology Partnership
Streamlining the path from cancer diagnosis to survivorship for better outcomes.Sam Brusco, Associate Editor 06.07.21
-
Chronic Disease
Medtronic Receives CE Marks for InPen and Guardian 4 Sensor
New portfolio of diabetes products will launch in Europe later this year.Charles Sternberg, Assistant Editor 06.02.21
-
Chronic Disease | Digital Health
Baxter Launches Sharesource Analytics 1.0 for Dialysis
Digital health module to enhance clinical management of home dialysis patients.Sam Brusco, Associate Editor 06.02.21
-
Chronic Disease
Koya Medical Receives FDA 510(k) Clearance for Active Compression Therapy System
Appoints additional executive leaders to support commercialization.Charles Sternberg, Assistant Editor 06.02.21
-
Chronic Disease
Ibex Medical Analytics Earns CE Mark for Galen Breast Solution
Demonstrates very high accuracy in detecting multiple types of breast cancer in a blinded study.Charles Sternberg, Assistant Editor 06.01.21
-
Chronic Disease
Avenda Health’s Male ‘Lumpectomy’ Receives Breakthrough Device Designation
The AI-based focal therapy system is designed to treat prostate cancer.Charles Sternberg, Assistant Editor 05.13.21
-
Chronic Disease
NXgenPort Enters License Agreement with Mayo Clinic
Collaboration advances the company’s development and product testing efforts.Charles Sternberg, Assistant Editor 05.12.21
-
Chronic Disease
Bigfoot Unity Diabetes Management System Cleared by FDA
Provides on-demand, insulin dose decision support to minimize guesswork and enable patients to follow their doctor’s instructions.Charles Sternberg, Assistant Editor 05.11.21
-
Chronic Disease | Diagnostics
GE Healthcare Buys Zionexa, a Breast Cancer Dx Startup
Acquired molecular imaging agent aims for more targeted metastatic breast cancer treatment.Sam Brusco, Associate Editor 05.06.21
-
Chronic Disease | Digital Health
Glooko, Eli Lilly Begin Connected Insulin Pen Collaboration
Will integrate Lilly's Tempo Pen and Tempo Smart Button with Glooko's platform.Sam Brusco, Associate Editor 05.06.21
-
Chronic Disease
BD to Spin Off Diabetes Care Biz
Transaction is expected to be completed in the first half of 2022.Sam Brusco, Associate Editor 05.06.21
-
Chronic Disease
Medtronic’s Emprint Ablation Catheter Kit Receives FDA Breakthrough Designation
Minimally invasive option has potential to provide long-term management of lung malignancies while protecting lung function.Charles Sternberg, Assistant Editor 04.28.21
-
Chronic Disease
BD Receives 510(k) Clearance for Pristine Catheter
The clearance was supported by clinical data from a feasibility study with favorable primary patency rates observed out to 180 days.Charles Sternberg, Assistant Editor 04.15.21
-
Chronic Disease
Medtronic Introduces Extended Infusion Set in Europe
Can be worn for up to seven days so users can safely stay on insulin pump therapy with fewer interruptions and insertions.Charles Sternberg, Assistant Editor 04.14.21
